ID23908A - Metode pengobatan dari penyakit trombosis - Google Patents

Metode pengobatan dari penyakit trombosis

Info

Publication number
ID23908A
ID23908A IDW991482A ID991482A ID23908A ID 23908 A ID23908 A ID 23908A ID W991482 A IDW991482 A ID W991482A ID 991482 A ID991482 A ID 991482A ID 23908 A ID23908 A ID 23908A
Authority
ID
Indonesia
Prior art keywords
treatment
combination therapy
result
limited
trombosis
Prior art date
Application number
IDW991482A
Other languages
English (en)
Indonesian (id)
Inventor
Brian William Grinnell
Jodeph Anthony Jakubowski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID23908A publication Critical patent/ID23908A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
IDW991482A 1997-06-05 1998-06-01 Metode pengobatan dari penyakit trombosis ID23908A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4862897P 1997-06-05 1997-06-05

Publications (1)

Publication Number Publication Date
ID23908A true ID23908A (id) 2000-05-25

Family

ID=21955575

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991482A ID23908A (id) 1997-06-05 1998-06-01 Metode pengobatan dari penyakit trombosis

Country Status (23)

Country Link
US (1) US6071514A (fr)
EP (1) EP0882453B1 (fr)
JP (1) JP2002502421A (fr)
KR (1) KR20010013413A (fr)
CN (2) CN1265598A (fr)
AT (1) ATE286404T1 (fr)
AU (1) AU741983B2 (fr)
BR (1) BR9809932A (fr)
CA (1) CA2293429A1 (fr)
DE (1) DE69828462T2 (fr)
DK (1) DK0882453T3 (fr)
EA (1) EA199901112A1 (fr)
ES (1) ES2235291T3 (fr)
HU (1) HUP0003964A2 (fr)
ID (1) ID23908A (fr)
NO (1) NO995776L (fr)
PL (1) PL337223A1 (fr)
PT (1) PT882453E (fr)
SI (1) SI0882453T1 (fr)
TR (1) TR199903020T2 (fr)
TW (1) TWI228042B (fr)
WO (1) WO1998055142A1 (fr)
ZA (1) ZA984698B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062828A1 (fr) 1996-04-30 2000-10-26 Medtronic, Inc. Fibrine autologue d'obturation et ses methodes de fabrication
DE29723807U1 (de) * 1996-04-30 1999-11-04 Medtronic, Inc., Minneapolis, Minn. Autologe Fibrin-Blutstillungsmittel
US6747003B1 (en) * 1997-10-23 2004-06-08 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7247708B2 (en) 1997-10-23 2007-07-24 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6693075B1 (en) * 1997-10-23 2004-02-17 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6953568B1 (en) * 1998-08-25 2005-10-11 Oklahoma Medical Research Foundation Targeting of molecules to large vessel endothelium using EPCR
EP1093814A1 (fr) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Utilisation du dipyridamole ou du mopidamol dans la fabrication d'un médicament pour le traitement et la prévention des troubles de la microcirculation dépendants de la fibrine
US7074402B2 (en) * 2000-02-04 2006-07-11 The Scripps Research Institute Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC)
US7812132B2 (en) * 2000-04-28 2010-10-12 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US20030056244A1 (en) * 2000-05-02 2003-03-20 Ning Huang Feed additive compositions and methods
US20030211094A1 (en) 2001-06-26 2003-11-13 Nelsestuen Gary L. High molecular weight derivatives of vitamin k-dependent polypeptides
US8906894B1 (en) 2000-07-27 2014-12-09 Thomas N. Thomas Methods for preventing and treating thrombotic disorders
WO2002030889A2 (fr) * 2000-10-13 2002-04-18 The Trustees Of Columbia University In The City Of New York Methode pour inhiber une nouvelle croissance tissulaire dans les vaisseaux sanguins d'un patient presentant une lesion
US6942880B1 (en) * 2001-04-09 2005-09-13 Medtronic, Inc. Autologous platelet gel having beneficial geometric shapes and methods of making the same
US7064130B2 (en) * 2001-04-20 2006-06-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
AU2002327649A1 (en) * 2001-09-19 2003-04-01 Mcmaster University Treatment of sepsis with tafi
US20030073636A1 (en) * 2001-09-19 2003-04-17 Oklahoma Medical Research Foundation Method of treating diabetes
EP1448205B1 (fr) 2001-10-05 2011-03-23 Zalicus Inc. Combinaisons permettant le traitement des troubles immunoinflammatoires
EP2390270A1 (fr) 2003-01-10 2011-11-30 Ablynx N.V. Polypeptides thérapeutiques, leurs homologues, leurs fragments et leur utilisation pour la modulation de l'agrégation de plaquettes
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
EP1773371A4 (fr) * 2004-07-23 2009-12-30 Univ Rochester La proteine c activee inhibe les effets secondaires de l'activateur de plasminogene dans le cerveau
JP5844028B2 (ja) * 2006-04-04 2016-01-13 ケージー アクキュイシチオン エルエルシー 抗血小板薬及び酸阻害薬を含む経口剤形
WO2007127834A2 (fr) * 2006-04-26 2007-11-08 Medtronic, Inc. Compositions et leurs méthodes d'élaboration
WO2007139753A2 (fr) * 2006-05-22 2007-12-06 Combinatorx, Incorporated Méthodes et compositions pour le traitement de maladies ou d'affections associées à des taux accrus de protéine c réactive, d'interleukine 6 ou d'interféron gamma
KR20150041173A (ko) 2007-04-27 2015-04-15 사이덱스 파마슈티칼스, 인크. 클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법
WO2009038708A1 (fr) * 2007-09-19 2009-03-26 Combinatorx, Incorporated Régimes thérapeutiques pour le traitement de troubles immunoinflammatoires
CN101938996A (zh) * 2007-12-17 2011-01-05 康宾纳特克斯公司 用于治疗免疫炎症性紊乱的治疗方案
DE102007063234A1 (de) * 2007-12-31 2009-07-02 Nowak, Attila, Dipl.-Ing. Schnellere Speicherorganisation
US20100280594A1 (en) * 2009-05-01 2010-11-04 Medi-Solve, Llc Antithrombotic Neurovascular Device Containing a Glycoprotein IIB/IIIA Receptor Inhibitor for The Treatment of Brain Aneurysms and/or Acute Ischemic Stroke, and Methods Related Thereto
KR101743591B1 (ko) 2009-05-13 2017-06-20 사이덱스 파마슈티칼스, 인크. 프라수그렐 및 사이클로덱스트린 유도체를 포함하는 약학 조성물 및 그의 제조 및 사용 방법
CN108159399B (zh) * 2017-12-29 2020-07-24 华中科技大学同济医学院附属同济医院 一种凝血蛋白酶aPC在防治糖尿病心肌病药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
US5516650A (en) * 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
IL97312A (en) * 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
FR2671973A1 (fr) * 1991-01-25 1992-07-31 Fondation Nale Transfusion San Utilisation de la proteine c activee comme agent anti-agregant plaquettaire.
WO1993009807A1 (fr) * 1991-11-18 1993-05-27 The Scripps Research Institute Procedes d'inhibition de la thrombose par elevation des taux de proteine c activee endogene dans la circulation
JPH05271098A (ja) * 1992-03-26 1993-10-19 Teijin Ltd 活性化プロテインｃを有効成分とする抗血小板剤
MY110664A (en) * 1992-05-21 1999-01-30 Lilly Co Eli Protein c derivatives
IL110172A (en) * 1993-07-22 2001-10-31 Lilly Co Eli Bicycle compounds and pharmaceuticals containing them
WO1997020043A1 (fr) * 1995-11-30 1997-06-05 Zymogenetics, Inc. Production de proteine c chez des animaux transgeniques

Also Published As

Publication number Publication date
PL337223A1 (en) 2000-08-14
BR9809932A (pt) 2000-08-01
CN1347734A (zh) 2002-05-08
JP2002502421A (ja) 2002-01-22
TWI228042B (en) 2005-02-21
ES2235291T3 (es) 2005-07-01
DE69828462T2 (de) 2005-12-15
DK0882453T3 (da) 2005-05-09
WO1998055142A1 (fr) 1998-12-10
KR20010013413A (fr) 2001-02-26
US6071514A (en) 2000-06-06
ZA984698B (en) 2000-02-01
NO995776D0 (no) 1999-11-25
EP0882453A3 (fr) 2001-04-04
NO995776L (no) 2000-01-26
TR199903020T2 (xx) 2000-08-21
HUP0003964A2 (en) 2001-03-28
AU7710098A (en) 1998-12-21
EP0882453A2 (fr) 1998-12-09
CN1265598A (zh) 2000-09-06
AU741983B2 (en) 2001-12-13
PT882453E (pt) 2005-04-29
EA199901112A1 (ru) 2000-06-26
ATE286404T1 (de) 2005-01-15
SI0882453T1 (en) 2005-06-30
DE69828462D1 (de) 2005-02-10
EP0882453B1 (fr) 2005-01-05
CA2293429A1 (fr) 1998-12-10

Similar Documents

Publication Publication Date Title
ID23908A (id) Metode pengobatan dari penyakit trombosis
BR0212039B1 (pt) dispositivo terapêutico a laser de nìvel baixo.
EP1767197A3 (fr) Trategies therapeutiques pour la prevention et le traitement de la maladie d'alzheimer
EA200300953A1 (ru) Терапевтические комбинации для применения при сердечно-сосудистых и воспалительных заболеваниях
DE69528604D1 (de) Medikamentenbehandlung erkrankter tiefliegender bereiche im inneren des körpers
NO920946L (no) Oral antikoagulant/blodplateinhibitor i lavdoseformulering
ES2133413T3 (es) Gel de lecitina inyectable.
ATE279922T1 (de) Behandlung von zns-wirkungen des hiv mit vx-478, allein oder kombiniert mit azt oder 3tc
ATE218854T1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase
DK0739212T3 (da) Anvendelse af interleukin-12 til forebyggelse af transplantat-vs.-værtssygdom
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
DK0680323T3 (da) Synergistisk kombination med antagonistvirkning ved NK1- og Nk2-receptorer.
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
HUP0002836A2 (hu) Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására
DE60045638D1 (de) Vermeidung und behandlung von krankheiten, die mit der blutgerinnung in zusammenhang stehen
TR200002939T2 (tr) Paroksetin maleat
ATE289201T1 (de) Zubereitung zur behandlung von flächigen, offenen wunden
CA2297984A1 (fr) Extraits de ratites comme agents therapeutiques
DK0836853T3 (da) Anvendelse af bradykinin-antagonister til fremstilling af lægemidler til behandling og forebyggelse af Alzheimers sygdom
ATE314073T1 (de) Kombination von aktiva mit alfuzosin und apomorphin
PT1351680E (pt) Utilizacao de anetole-ditioletiona na prevencao e tratamento da tenotoxicidade induzida por um medicamento
ITNA20020028A1 (it) Nuove applicazioni terapeutiche per prevenire l'insuccesso dell'impianto di endoprotesi, o stents, e l'occlusione dei graft venosi mediante
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
NO994339D0 (no) Anvendelse av <alfa>1-surt glykoprotein ved fremstilling av et farmasöytisk preparat